14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.22 $1.62 Friday, 3rd May 2024 AKBA stock ended at $1.37. This is 5.38% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.58% from a day low at $1.32 to a day high of $1.42.
90 days $1.22 $2.47
52 weeks $0.780 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Jul 23, 2020 $12.26 $12.64 $11.88 $11.98 779 364
Jul 22, 2020 $12.44 $12.60 $12.11 $12.25 475 300
Jul 21, 2020 $12.88 $13.00 $12.28 $12.44 932 500
Jul 20, 2020 $12.80 $13.14 $12.44 $12.88 1 066 800
Jul 17, 2020 $12.21 $12.74 $12.18 $12.36 786 600
Jul 16, 2020 $12.27 $12.31 $11.90 $12.28 641 800
Jul 15, 2020 $12.26 $12.45 $11.85 $12.35 818 000
Jul 14, 2020 $11.90 $12.24 $11.57 $11.91 925 200
Jul 13, 2020 $12.08 $12.49 $11.79 $11.83 1 182 600
Jul 10, 2020 $12.50 $12.56 $11.95 $11.98 863 600
Jul 09, 2020 $13.02 $13.15 $12.36 $12.50 861 900
Jul 08, 2020 $13.08 $13.50 $12.86 $13.03 1 103 800
Jul 07, 2020 $12.88 $13.71 $12.87 $13.03 1 787 800
Jul 06, 2020 $13.40 $13.40 $12.75 $13.06 1 094 300
Jul 02, 2020 $13.03 $13.30 $12.80 $13.08 1 275 758
Jul 01, 2020 $13.52 $13.59 $12.09 $12.90 3 053 463
Jun 30, 2020 $12.67 $13.68 $12.35 $13.58 2 466 308
Jun 29, 2020 $12.06 $12.73 $11.83 $12.70 1 870 425
Jun 26, 2020 $12.51 $12.60 $11.40 $11.68 5 593 266
Jun 25, 2020 $12.24 $12.68 $12.05 $12.55 2 199 263
Jun 24, 2020 $12.35 $12.68 $11.93 $12.31 1 314 909
Jun 23, 2020 $12.70 $12.84 $12.44 $12.54 1 446 359
Jun 22, 2020 $11.94 $12.57 $11.55 $12.55 1 328 833
Jun 19, 2020 $12.56 $12.68 $11.80 $11.83 4 355 264
Jun 18, 2020 $12.16 $12.62 $12.16 $12.61 1 127 923
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT